January 24, 2018 / 3:15 AM / 3 months ago

BRIEF-Shanghai Fosun Pharmaceutical Group units receive approval for drug clinical trials

Reuters Staff

1 Min Read

Jan 24 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd

* Says two pharmaceutical units received drug clinical trials approval for capsule FCN-437c and crude drug, which will be mainly used for treatment of solid tumor

Source text in Chinese:goo.gl/KA8dec

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.